Variant report

Variant	esv3526869
Chromosome Location	chr7:4079319-4083656
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:4082285..4084220-chr7:4087738..4090486,2	K562	blood:

Extended variants
information (count: 243 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:243 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs572175726	chr7:4079362-4079363	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs541088018	chr7:4079363-4079364	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs6462545	chr7:4079412-4079413	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs149378924	chr7:4079423-4079424	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs78923606	chr7:4079437-4079438	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs80084741	chr7:4079438-4079439	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs6462546	chr7:4079451-4079452	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs576448872	chr7:4079454-4079455	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs563210549	chr7:4079457-4079458	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs6462547	chr7:4079464-4079465	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs6462548	chr7:4079500-4079501	Enhancers Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs564892754	chr7:4079513-4079514	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs190760848	chr7:4079517-4079518	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs183358031	chr7:4079526-4079527	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs146343310	chr7:4079536-4079537	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs547480529	chr7:4079540-4079541	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs188573752	chr7:4079548-4079549	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs529885615	chr7:4079552-4079553	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs545898955	chr7:4079605-4079606	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs549678064	chr7:4079612-4079613	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs370642431	chr7:4079613-4079614	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs569957177	chr7:4079646-4079647	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs6462549	chr7:4079695-4079696	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs6462550	chr7:4079710-4079711	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs114779938	chr7:4079734-4079735	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs6462551	chr7:4079741-4079742	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs201346122	chr7:4079791-4079792	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs192968705	chr7:4079792-4079793	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs554634082	chr7:4079802-4079803	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs574414979	chr7:4079805-4079806	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs78568092	chr7:4079815-4079816	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs556433034	chr7:4079834-4079835	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs528981087	chr7:4079842-4079843	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs576335592	chr7:4079851-4079852	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs80285963	chr7:4079910-4079911	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs74428814	chr7:4079913-4079914	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs144726310	chr7:4079939-4079940	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs117463376	chr7:4079946-4079947	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs4526263	chr7:4079956-4079957	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs561451077	chr7:4079964-4079965	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs79412485	chr7:4079985-4079986	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs549952894	chr7:4079986-4079987	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs148516002	chr7:4080014-4080015	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs368699957	chr7:4080033-4080034	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs532490409	chr7:4080037-4080038	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs112233724	chr7:4080049-4080050	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs77775006	chr7:4080080-4080081	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs534616833	chr7:4080090-4080091	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs547847271	chr7:4080091-4080092	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs200193288	chr7:4080094-4080095	Enhancers Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Chordoma	21602918	CNVD
Lynch syndrome	22585707	CNVD
Follicular lymphoma	20505157	CNVD
Breast cancer	16397240	CNVD
Raine Syndrome	17924334	CNVD
Diffuse large b-cell lymphoma	21266526	CNVD
Melanoma	18172304	CNVD
Sudden cardiac death	19188705	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Glioma	18556773	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
Spondylocostal dysostosis	21085971	CNVD
Mental retardation	17901693	CNVD
Heart disease	21282601	CNVD
Glioblastoma multiforme	22286061	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	17053054	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21645411	CNVD
Intellectual disability	21811512	CNVD
Breast cancer	22522925	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Urothelial carcinoma	21177765	CNVD

Chromatin state (count:69 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:4059000-4091200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr7:4061400-4080800	Weak transcription	Pancreatic Islets	Pancreatic Islet
3	chr7:4066800-4082000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
4	chr7:4066800-4087200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr7:4066800-4091200	Weak transcription	Pancreas	Pancrea
6	chr7:4074000-4079600	Weak transcription	H9 Cell Line	embryonic stem cell
7	chr7:4077800-4087800	Weak transcription	Spleen	Spleen
8	chr7:4078000-4091200	Weak transcription	Aorta	Aorta
9	chr7:4078400-4081200	Weak transcription	Fetal Muscle Leg	muscle
10	chr7:4078600-4079600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
11	chr7:4079000-4079600	Enhancers	H1 Cell Line	embryonic stem cell
12	chr7:4079000-4080000	Enhancers	iPS-18 Cell Line	embryonic stem cell
13	chr7:4079200-4079800	Enhancers	iPS-15b Cell Line	embryonic stem cell
14	chr7:4079200-4080000	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr7:4079200-4080200	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr7:4079200-4080200	Enhancers	HUES64 Cell Line	embryonic stem cell
17	chr7:4079400-4079600	Active TSS	iPS-20b Cell Line	embryonic stem cell
18	chr7:4079600-4079800	Enhancers	H9 Cell Line	embryonic stem cell
19	chr7:4079600-4080000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr7:4079600-4080200	Flanking Active TSS	H1 Cell Line	embryonic stem cell
21	chr7:4079600-4080800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
22	chr7:4079600-4081400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
23	chr7:4079600-4083800	Enhancers	HUES6 Cell Line	embryonic stem cell
24	chr7:4079800-4080200	Active TSS	ES-WA7 Cell Line	embryonic stem cell
25	chr7:4079800-4080200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
26	chr7:4079800-4080200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr7:4079800-4080400	Active TSS	H9 Cell Line	embryonic stem cell
28	chr7:4079800-4080400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr7:4080000-4080200	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
30	chr7:4080000-4080400	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
31	chr7:4080200-4080600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
32	chr7:4080200-4081200	Weak transcription	HUES64 Cell Line	embryonic stem cell
33	chr7:4080200-4081600	Enhancers	H1 Cell Line	embryonic stem cell
34	chr7:4080200-4082000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr7:4080200-4083800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
36	chr7:4080200-4083800	Enhancers	iPS-15b Cell Line	embryonic stem cell
37	chr7:4080200-4083800	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr7:4080400-4080600	Flanking Active TSS	H9 Cell Line	embryonic stem cell
39	chr7:4080400-4080800	Enhancers	HUES48 Cell Line	embryonic stem cell
40	chr7:4080400-4080800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr7:4080600-4081200	Enhancers	ES-I3 Cell Line	embryonic stem cell
42	chr7:4080600-4084000	Enhancers	H9 Cell Line	embryonic stem cell
43	chr7:4080800-4081400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr7:4080800-4082200	Weak transcription	HUES48 Cell Line	embryonic stem cell
45	chr7:4080800-4083200	Enhancers	iPS-20b Cell Line	embryonic stem cell
46	chr7:4081200-4081400	Enhancers	HUES64 Cell Line	embryonic stem cell
47	chr7:4081200-4081400	Enhancers	Fetal Muscle Leg	muscle
48	chr7:4081400-4081800	Weak transcription	HUES64 Cell Line	embryonic stem cell
49	chr7:4081400-4082200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
50	chr7:4081400-4082200	Weak transcription	Fetal Muscle Leg	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links